Eli Lilly Subpoenaed
Eli Lilly said it received a subpoena in November from a U.S. grand jury in Pennsylvania seeking documents involving the marketing of the company’s best-selling drug, the antipsychotic Zyprexa. It is cooperating in state and U.S. investigations into its marketing practices, according to spokeswoman Marni Lemons.
Lemons’s statement also cited “many speculative statements” in a New York Times article that said the drugmaker may pay more than $1 billion to settle the investigation. “We regularly have discussions with the government,” Lemons said. She didn’t comment further on the Times article.